Bleeding Complications Up With Multicompartment Mesh Removal

Share this content:
Bleeding Complications Up With Multicompartment Mesh Removal
Bleeding Complications Up With Multicompartment Mesh Removal

(HealthDay News) -- For women undergoing vaginal mesh removal, bleeding complications are higher for removal from multiple vaginal compartments versus a single vaginal compartment, according to research published May 6 in Obstetrics & Gynecology.

Stephanie D. Pickett, M.D., from the University of Oklahoma Health Sciences Center in Oklahoma City, and colleagues conducted a retrospective review to examine perioperative complications of mesh removal performed in the operating room. The authors compared the morbidity associated with single-compartment mesh removal (326 patients) versus removal from multiple vaginal compartments (48 patients) during a 75-month period.

The researchers found that pain, dyspareunia, mesh exposure, and voiding dysfunction were indications for mesh removal (63, 57, 54, and 39 percent, respectively). Mesh removed had a mean length of 4 cm. Estimated blood loss was approximately three times higher for multicompartment surgery versus single-compartment surgery (P < 0.001). Compared with single-compartment surgery, the odds of transfusion were more than nine times higher after multicompartment surgery (odds ratio, 9.7; P < 0.01).

"When removing mesh materials, multiple-compartment surgery carries a greater risk of a bleeding morbidity compared to single-compartment surgery," the authors write. "This information will supplement the knowledge of the consulting surgeon as to the best way to manage and plan mesh removal surgery."

One author disclosed financial ties to the medical device and biotechnology industries.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »